Class Action Group Of The Year: Kirkland
Kirkland & Ellis LLP successfully defended AbbVie from a novel theory that it had created a "patent thicket" around its immunosuppressant drug Humira to block cheaper biosimilars from coming onto the...To view the full article, register now.
Already a subscriber? Click here to view full article